Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil (Q34398193)

1 August 2017

title

Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil (English)

1 reference

1 August 2017

3

B W McCrindle

1 reference

1 August 2017

A I Dipchand

1

1 reference

1 August 2017

B Pietra

series ordinal

2

1 reference

1 August 2017

H L Rosebrook-Bicknell

series ordinal

4

1 reference

1 August 2017

M M Boucek

series ordinal

5

1 reference

1 August 2017

publication date

1 October 2001

1 reference

The Journal of Heart and Lung Transplantation

1 August 2017

published in

1 reference

1 August 2017

volume

20

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1035-1043

1 reference

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Mycophenolate mofetil in cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Scientific principles for mycophenolic acid therapeutic drug monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Pharmacokinetics of mycophenolate mofetil in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

RS-61443--a phase I clinical trial and pilot rescue study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Drug monitoring of mycophenolic acid in the early period after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900305-9

7 January 2021

10.1016/S1053-2498(01)00305-9

Identifiers

DOI

1 reference

1 August 2017

1 reference